Patents by Inventor Iolanda M. Fierro

Iolanda M. Fierro has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Lipoxin analogs as novel inhibitors of angiogenesis
    Patent number: 8008282
    Abstract: The present invention is directed to methods for the prevention or inhibition of angiogenesis. The method is accomplished by the administration of an effective amount of 15-epi-16-(para-fluoro)-phenoxy-lipoxin A4, LXA4, 15-epi-LXA4 or 15-R/S-methyl, LXA4 and pharmaceutically acceptable salts, esters, amides, carboxylic acids, or prodrugs thereof, to a subject in need thereof. As a consequence of the action of the therapeutic agent, angiogenesis is prevented or inhibited in the subject.
    Type: Grant
    Filed: September 8, 2005
    Date of Patent: August 30, 2011
    Assignee: The Brigham & Women's Hospital, Inc.
    Inventors: Charles N. Serhan, Iolanda M. Fierro
  • Lipoxin analogs as novel inhibitors of angiogenesis
    Publication number: 20040053998
    Abstract: The present invention is directed to methods for the prevention or inhibition of angiogenesis. The method is accomplished by the administration of an effective amount of 15-epi-16-(para-fluoro)-phenoxy-lipoxin A4, LXA4, 15-epi-LXA4 or 15-R/S-methyl, LXA4 and pharmaceutically acceptable salts, esters, amides, carboxylic acids, or prodrugs thereof, to a subject in need thereof. As a consequence of the action of the therapeutic agent, angiogenesis is prevented or inhibited in the subject.
    Type: Application
    Filed: July 8, 2003
    Publication date: March 18, 2004
    Inventors: Charles N. Serhan, Iolanda M. Fierro
  • Lipoxin analogs as novel inhibitors of angiogenesis
    Patent number: 6627658
    Abstract: The present invention is directed to methods for the prevention or inhibition of angiogenesis. The method is accomplished by the administration of an effective amount of 15-epi-16-(para-fluoro)-phenoxy-lipoxin A4, LXA4, 15-epi-LXA4 or 15-R/S-methyl, LXA4 and pharmaceutically acceptable salts, esters, amides, carboxylic acids, or prodrugs thereof, to a subject in need thereof. As a consequence of the action of the therapeutic agent, angiogenesis is prevented or inhibited in the subject.
    Type: Grant
    Filed: March 1, 2002
    Date of Patent: September 30, 2003
    Assignee: The Brigham and Women's Hospital
    Inventors: Charles N. Serhan, Iolanda M. Fierro
  • Lipoxin analogs as novel inhibitors of angiogenesis
    Publication number: 20020193431
    Abstract: The present invention is directed to methods for the prevention or inhibition of angiogenesis. The method is accomplished by the administration of an effective amount of 15-epi-16-(para-fluoro)-phenoxy-lipoxin A4, LXA4, 15-epi-LXA4 or 15-R/S-methyl, LXA4 and pharmaceutically acceptable salts, esters, amides, carboxylic acids, or prodrugs thereof, to a subject in need thereof. As a consequence of the action of the therapeutic agent, angiogenesis is prevented or inhibited in the subject.
    Type: Application
    Filed: March 1, 2002
    Publication date: December 19, 2002
    Inventors: Charles N. Serhan, Iolanda M. Fierro